The Ocular Immunology and Uveitis Foundation

Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (601-650)

Previous 50   Next 50

601. Azathioprine for ocular inflammatory diseases. Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Am J Ophthalmol. 2009 Oct;148(4):500-509.e2. Epub 2009 Jul 1.

602. Local treatment for lymphoid malignancies of the eye. Giuliari GP, Hinkle DM, Foster CS. Anticancer Agents Med Chem. 2009 Dec;9(10):1123-8. Review.

603.Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease. Zakka FR, Chang PY, Giuliari GP, Foster CS. Clin Ophthalmol. 2009;3:567-79. Epub 2009 Oct 19.

604. Clinical review: treatment of vitreoretinal lymphoma. Pe'er J, Hochberg FH, Foster CS. Ocul Immunol Inflamm. 2009 Sep-Oct;17(5):299-306. Review.

605. Infliximab for the treatment of refractory scleritis. Doctor P, Sultan A, Syed S, Christen W, Bhat P, Foster CS. Br J Ophthalmol. 2010 May;94(5):579-83. Epub 2009 Dec 2.

606. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis. Papadaki T, Iaccheri B, Fiore T, Zacharopoulos I, Thadani S, Christen W, Androudi S, Foster CS. Acta Ophthalmol. 2010 Mar;88(2):e28-9. Epub 2009 Jun 2.

607. Cataracts and uveitis. Jancevski M, Foster CS. Discov Med. 2010 Jan;9(44):51-4.

608. Cyclosporine for ocular inflammatory diseases. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Ophthalmology. 2010 Mar;117(3):576-84. Epub 2010 Jan 19.

609. Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts Eye Research and Surgery Institution experience. Giuliari GP, Chang PY, Thakuria P, Hinkle DM, Foster CS. Eye (Lond). 2010 Jan;24(1):7-13. Epub 2010 Jan 8. Erratum in: Eye (Lond). 2010 May;24(5):946

610. Mycophenolate mofetil for ocular inflammation. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2. Epub 2009 Dec 30.

611. Ocular disease in patients with ANCA-positive vasculitis. Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, Nussenblatt RB, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Suhler EB, Smith JR. J Ocul Biol Dis Infor. 2009 Dec 12;3(1):12-19.

612. Cataracts and uveitis. Jancevski M, Foster CS. Discov Med. 2010 Jan;9(44):51-4.

613. Ceron OM, Hinkle DM, Foster CS.  Intraocular Inflammatory Disorders Update.  Retinal Physician. 2009 Feb:24-8.

614. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Foster CS, Chang PY, Ahmed AR. Ophthalmology. 2010 May;117(5):861-9. Epub 2010 Jan 4.

615. The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. Giuliari G, Hinkle DM, Foster CS. J Ophthalmol. 2009;2009:567693. Epub 2010 Feb 8.

616. Amorese L, Foster CS.  Parasitic Keratitis.  Contemporary Ophthalmology.  2010 Jan 15.

617. Multicenter Uveitis Steroid Treatment Trial Research Group. The Multicenter Uveitis Steroid Treatment (MUST) Trial: Rationale, Design and Baseline Characteristics. Am J Ophthalmol 2010;149:550-561. e10. Epub 2010 Jan 25.

618. Cyclophosphamide for ocular inflammatory diseases. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Ophthalmology. 2010 Feb;117(2):356-65. Epub 2009 Dec 6.

619. Hypopyon in patients with uveitis. Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Ophthalmology. 2010 Feb;117(2):366-72. Epub 2009 Dec 14.

620. Tumalad M, Mansoor A, Foster CS.  Ocular Manifestations of Herpes Simplex Virus Infection.  Contemporary Ophthalmology.  2010 Feb 28.

621. Mycophenolate mofetil for ocular inflammation. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2

622. Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Fiorelli VM, Bhat P, Foster CS. Ocul Immunol Inflamm. 2010 Apr;18(2):116-20.

623. Durrani K, Foster CS.  Management of Uveitis: Current concepts and modalitites. Contemporary Ophthalmology. 2010 Apr 30.

624. Lee F, Foster CS.  Pharmacotherapy of Uveitis. Expert Opinion on Pharmacotherapy.  2010 May;11(7):1135-46.

625. Masood K, Foster CS.  Birdshot Retinochoroidopathy: An Updated Review of Diagnosis, Treatment, and Management Options.  Contemporary Ophthalmology.  2010 May 15.

626. Siddique SS, Foster CS.  Central Serous Chorioretinopathy.  Contemporary Ophthalmology.  2010 Jun 15.

627. Adverse effects of smoking on patients with ocular inflammation. Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Br J Ophthalmol. 2010 Jul;94(7):848-53.

628. Portero-Benito A, Foster CS.  Ocular Albinism.  Contemporary Ophthalmology.  2010 Jul 15.

629. Mehta M, Foster CS.  Histopathologic Differential Diagnosis of Common Eyelid Lesions.  Contemporary Ophthalmology.  2010 Jul 30.

630. Microperimetry findings in patients with birdshot chorioretinopathy. Giuliari GP, Pujari S, Shaikh M, Marvell D, Foster CS. Can J Ophthalmol. 2010 Aug;45(4):399-403.

631. Keratoprosthesis in autoimmune disease. Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J. Ocul Immunol Inflamm. 2010 Aug;18(4):275-80.

632. Villaneuva- Palafox SK, Shaikh M, Foster CS.  Neuromyelitis Optica (Devic’s Disease) :  An entity distinct from multiple sclerosis.  Contemporary Ophthalmology.  2010 Aug 15.

633. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. J Ocul Pharmacol Ther. 2010 Oct;26(5):475-83.

634. Recurrent conjunctivitis and scleritis secondary to coexistent conjunctival pemiphigus vulgaris and cryptic herpes simplex infection: a case report. Mehta M, Dacey M, Stephen Foster C. Ocul Immunol Inflamm. 2010 Dec;18(6):454-6. Epub 2010 Sep 2.

635. Scleral necrosis in a patient with congenital erythropoietic porphyria. Siddique SS, Gonzalez-Gonzalez LA, Thakuria P, Chang PY, Foster CS. Cornea. 2011 Jan;30(1):97-9.

636. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Ocul Immunol Inflamm. 2010 Oct;18(5):411-7.

637. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F. Sci Transl Med. 2010 Oct 6.

638. Krader CG, Foster CS. Dexamethasone Implant an Option For Posterior Segment Uveitis. Ophthalmology Times. 2010 Oct 15; 35 (20): 1, 11.

639. Herpes keratitis in a patient undergoing treatment with topical mitomycin C. Siddique SS, Gonzalez-Gonzalez LA, Amorese L, Shaikh M, Foster S. Cornea. 2011 Apr;30(4):466-7.

640. Anterior segment optical coherence tomography. Jancevski M, Foster CS. Semin Ophthalmol. 2010 Sep-Nov;25.

641. Foster CS, Anesi S.  The Successful Approach to Ocular Rosacea.  Drugs and Disease, Refractive Eyecare.  Dec 2010: 11-12, 19.

642. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group. Arch Ophthalmol. 2011 May;129(5):545-53. Epub 2011 Jan 10.

643. Palafox SK, Smitha J, Tauber A, Foster CS.  Ophthalmia Neonatorum.  Journal of Clinical & Experimental Ophthalmology 2:119 (1-5).

644. Peter Y. Chang, Sana S. Siddique, Mehrine Shaikh and C. Stephen Foster. 2010, Topical corticosteroids in ocular diseases, Current Topics in Steroid Research, Vol. 7, 1-10.

645. Foster CS. Drug Delivery Mechanisms for the Treatment of Uveitis. Retina Today. 2011 March.

646. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Eye (Lond). 2011 Apr;25(4):427-35. Epub 2011 Mar 18.

647. Possible in vitro model of toxic epidermal necrolysis. Letko E, Bhol K, Foster CS, Ahmed AR. Arch Ophthalmol. 2011 May;129(5):666-7

648. The frequency of other autoimmune disorders in patients with ocular cicatricial pemphigoid. Anzaar F, Cabrita F, Ahmed M, Foster CS. Acta Ophthalmol. 2012 May;90(3):e253-4. doi: 10.1111/j.1755-3768.2011.02174.x. Epub 2011 May 19

649. Difluprednate for inflammatory eye disorders. Mulki L, Foster CS. Drugs Today (Barc). 2011 May;47(5):327-33.

650. Gonzalez-Gonzalez LA, Foster CS. Secukinumab.  Drugs of the Future.  2011 36(6): 441-445.


Previous 50
   Next 50